Literature DB >> 17667636

Illicit drugs and cardiac arrhythmias in athletes.

Francesco Furlanello1, Laura Vitali Serdoz, Riccardo Cappato, Luigi De Ambroggi.   

Abstract

The current management of athletes with cardiac arrhythmias has become complicated by the widespread use of illicit drugs, which can be arrhythmogenic. The World Anti-Doping Agency annually updates a list of prohibited substances and methods banned by the International Olympic Committee that includes different classes of substances namely, anabolic androgenic steroids, hormones and related substances, beta2-agonists, diuretics, stimulants, narcotics, cannabinoids, glucocorticosteroids, alcohol, beta-blockers and others. Almost all illicit drugs may cause, through a direct or indirect arrhythmogenic effect, a wide range of cardiac arrhythmias (focal or reentry type, supraventricular and/or ventricular) that can even be lethal and which are frequently sport activity related. A large use of illicit drugs has been documented in competitive athletes, but the arrhythmogenic effect of specific substances is not precisely known. Precipitation of cardiac arrhythmias, particularly in the presence of a latent electrophysiologic substrate including some inherited cardiomyopathies, at risk of sudden death or due to long-term consumption of the substances, should raise the suspicion that illicit drugs may be a possible cause and lead cardiologists to investigate carefully this relationship and appropriately prevent the clinical consequences.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17667636     DOI: 10.1097/HJR.0b013e3280ecfe3e

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  11 in total

Review 1.  The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis.

Authors:  Amy B Cadwallader; Xavier de la Torre; Alessandra Tieri; Francesco Botrè
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

2.  Sport nutrition and doping in tennis: an analysis of athletes' attitudes and knowledge.

Authors:  Miran Kondric; Damir Sekulic; Ognjen Uljevic; Goran Gabrilo; Milan Zvan
Journal:  J Sports Sci Med       Date:  2013-06-01       Impact factor: 2.988

Review 3.  [Sports cardiology : Overview of relevant clinical topics].

Authors:  R Laszlo; J Scharhag; C Burgstahler; H Striegel; J M Steinacker
Journal:  Herz       Date:  2017-01-23       Impact factor: 1.443

Review 4.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marin; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Eur J Prev Cardiol       Date:  2016-11-04       Impact factor: 7.804

Review 5.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marín; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Europace       Date:  2017-02-01       Impact factor: 5.214

6.  Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach.

Authors:  Miran Kondric; Damir Sekulic; Andrea Petroczi; Ljerka Ostojic; Jelena Rodek; Zdenko Ostojic
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-10-11

Review 7.  Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm.

Authors:  Suraj Achar; Armand Rostamian; Sanjiv M Narayan
Journal:  Am J Cardiol       Date:  2010-09-15       Impact factor: 2.778

Review 8.  Atrial fibrillation and long-term sports practice: epidemiology and mechanisms.

Authors:  S Wernhart; M Halle
Journal:  Clin Res Cardiol       Date:  2014-12-25       Impact factor: 5.460

9.  Chronic exercise: a contributing factor to atrial fibrillation?

Authors:  Xander H T Wehrens; David Y Chiang; Na Li
Journal:  J Am Coll Cardiol       Date:  2013-04-09       Impact factor: 24.094

10.  Dietary supplementation and doping-related factors in high-level sailing.

Authors:  Jelena Rodek; Damir Sekulic; Miran Kondric
Journal:  J Int Soc Sports Nutr       Date:  2012-12-07       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.